Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures

被引:0
|
作者
Furusawa, Yuri [1 ,2 ]
Kiso, Maki [3 ]
Uraki, Ryuta [1 ,2 ,3 ]
Sakai-Tagawa, Yuko [2 ]
Nagai, Hiroyuki [4 ]
Koga, Michiko [4 ,5 ]
Kashima, Yukie [6 ]
Hojo, Masayuki [7 ]
Iwamoto, Noriko [8 ]
Iwatsuki-Horimoto, Kiyoko [3 ]
Ohmagari, Norio [8 ]
Suzuki, Yutaka [6 ]
Yotsuyanagi, Hiroshi [4 ,5 ]
Halfmann, Peter J. [9 ]
Kamitani, Wataru [10 ]
Yamayoshi, Seiya [1 ,2 ,3 ,11 ]
Kawaoka, Yoshihiro [1 ,2 ,3 ,9 ]
机构
[1] Natl Ctr Global Hlth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Tokyo, Japan
[3] Univ Tokyo, Pandem Preparedness Infect & Adv Res Ctr, Tokyo, Tokyo, Japan
[4] Univ Tokyo, IMSUT Hosp, Inst Med Sci, Dept Infect Dis & Appl Immunol, Tokyo, Tokyo, Japan
[5] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Infect Dis, Tokyo, Tokyo, Japan
[6] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Tokyo, Japan
[7] Natl Ctr Global Hlth & Med, Dept Resp Dis, Tokyo, Tokyo, Japan
[8] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Tokyo, Japan
[9] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA
[10] Gunma Univ, Grad Sch Med, Dept Infect Dis & Host Def, Gunma, Japan
[11] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Tokyo, Japan
关键词
SARS-CoV-2; COVID-19; coronavirus;
D O I
10.1128/jvi.02217-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicates well at 37 degrees C, which is the temperature of the human lower respiratory tract, but it poorly at 30 degrees C-32 degrees C, which is the temperature of the human upper respiratory tract. The replication efficiency of SARS-CoV-2 in the upper respiratory tract may directly affect its transmissibility. In this study, an XBB.1.5 isolate showed superior replicative ability at 32 degrees C and 30 degrees C, whereas most other Omicron sub-variant isolates showed limited growth. Deep sequencing analysis demonstrated that the frequencies of viruses possessing the NSP6-S163P and NSP13-P238S substitutions increased to more than 97% during propagation of the XBB.1.5 isolate at 32 degrees C but did not reach 55% at 37 degrees C. Reverse genetics revealed that these substitutions contributed to superior virus growth in vitro at these low temperatures by improving virus genome replication. Mutant virus possessing both substitutions showed slightly higher virus titers in the upper respiratory tract of hamsters compared to the parental virus; however, transmissibility between hamsters was similar for the mutant and parental viruses. Taken together, our findings indicate that NSP6-S163P and NSP13-P238S contribute to superior virus growth at low temperatures in vitro and in the upper respiratory tract of hamsters. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicates efficiently at 37 degrees C. However, the temperature of the human upper airway is 30 degrees C-32 degrees C. Therefore, the replicative ability of SARS-CoV-2 at low temperatures could influence virus replication in the upper airway and transmissibility. In this study, we assessed the growth of Omicron sub-variants at low temperatures and found that an XBB.1.5 isolate showed increased replicative ability. By deep sequencing analysis and reverse genetics, we found that amino acid changes in NSP6 and NSP13 contribute to the low-temperature growth; these changes improved RNA polymerase activity at low temperatures and enhanced virus replication in the upper airway of hamsters. Although these substitutions alone did not drastically affect virus transmissibility, in combination with other substitutions, they could affect virus replication in humans. Furthermore, since these substitutions enhance virus replication in cultured cells, they could be used to improve the production of inactivated or live attenuated vaccine virus.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors
    Yazdi, Aliakbar Khalili
    Pakarian, Paknoosh
    Perveen, Sumera
    Hajian, Taraneh
    Santhakumar, Vijayaratnam
    Bolotokova, Albina
    Li, Fengling
    Vedadi, Masoud
    ACS INFECTIOUS DISEASES, 2022, 8 (08): : 1533 - 1542
  • [42] Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study
    Vivek-Ananth, R. P.
    Krishnaswamy, Sankaran
    Samal, Areejit
    MOLECULAR DIVERSITY, 2022, 26 (01) : 429 - 442
  • [43] Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations
    Vardhan, Seshu
    Sahoo, Suban K.
    JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2022, 12 (01): : 44 - 54
  • [44] Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation
    Nishitsuji, Hironori
    Iwahori, Satoko
    Ohmori, Mariko
    Shimotohno, Kunitada
    Murata, Takayuki
    MBIO, 2022, 13 (04):
  • [45] Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex
    Kuzikov, Maria
    Reinshagen, Jeanette
    Wycisk, Krzysztof
    Corona, Angela
    Esposito, Francesca
    Malune, Paolo
    Manelfi, Candida
    Iaconis, Daniela
    Beccari, Andrea
    Tramontano, Enzo
    Nowotny, Marcin
    Windshuegel, Bjorn
    Gribbon, Philip
    Zaliani, Andrea
    VIRUS RESEARCH, 2024, 343
  • [46] Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis
    Preeti Pandey
    Kartikay Prasad
    Amresh Prakash
    Vijay Kumar
    Journal of Molecular Medicine, 2020, 98 : 1659 - 1673
  • [47] Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)
    Ugurel, Osman Mutluhan
    Mutlu, Ozal
    Sariyer, Emrah
    Kocer, Sinem
    Ugurel, Erennur
    Inci, Tugba Gul
    Ata, Oguz
    Turgut-Balik, Dilek
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 163 : 1687 - 1696
  • [48] Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis
    Pandey, Preeti
    Prasad, Kartikay
    Prakash, Amresh
    Kumar, Vijay
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (12): : 1659 - 1673
  • [49] SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13
    Zhang, Bo
    Xie, Yan
    Lan, Zhaoling
    Li, Dayu
    Tian, Junjie
    Zhang, Qintao
    Tian, Hongji
    Yang, Jiali
    Zhou, Xinnan
    Qiu, Shuyi
    Lu, Keyu
    Liu, Yang
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [50] Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors
    Perez-Lemus, Gustavo R.
    Menendez, Cintia A.
    Alvarado, Walter
    Bylehn, Fabian
    de Pablo, Juan J.
    SCIENCE ADVANCES, 2022, 8 (01):